Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
Gautam SK, Kumar S, Cannon A, Hall B, Bhatia R, Nasser MW, Mahapatra S, Batra SK, Jain M. Gautam SK, et al. Among authors: nasser mw. Expert Opin Ther Targets. 2017 Jul;21(7):657-669. doi: 10.1080/14728222.2017.1323880. Epub 2017 May 29. Expert Opin Ther Targets. 2017. PMID: 28460571 Free PMC article. Review.
Emerging trends in the immunotherapy of pancreatic cancer.
Banerjee K, Kumar S, Ross KA, Gautam S, Poelaert B, Nasser MW, Aithal A, Bhatia R, Wannemuehler MJ, Narasimhan B, Solheim JC, Batra SK, Jain M. Banerjee K, et al. Among authors: nasser mw. Cancer Lett. 2018 Mar 28;417:35-46. doi: 10.1016/j.canlet.2017.12.012. Epub 2017 Dec 12. Cancer Lett. 2018. PMID: 29242097 Free PMC article. Review.
Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
Kanteti R, Mirzapoiazova T, Riehm JJ, Dhanasingh I, Mambetsariev B, Wang J, Kulkarni P, Kaushik G, Seshacharyulu P, Ponnusamy MP, Kindler HL, Nasser MW, Batra SK, Salgia R. Kanteti R, et al. Among authors: nasser mw. Cancer Biol Ther. 2018 Apr 3;19(4):316-327. doi: 10.1080/15384047.2017.1416937. Epub 2018 Feb 22. Cancer Biol Ther. 2018. PMID: 29303405 Free PMC article.
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.
Wang J, Mirzapoiazova T, Carol Tan YH, Pang KM, Pozhitkov A, Wang Y, Wang Y, Mambetsariev B, Wang E, Nasser MW, Batra SK, Raz D, Reckamp K, Kulkarni P, Zheng Y, Salgia R. Wang J, et al. Among authors: nasser mw. Cancer Biol Ther. 2018;19(11):1023-1032. doi: 10.1080/15384047.2018.1472193. Epub 2018 Oct 12. Cancer Biol Ther. 2018. PMID: 30311833 Free PMC article.
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells.
Mirzapoiazova T, Li H, Nathan A, Srivstava S, Nasser MW, Lennon F, Armstrong B, Mambetsariev I, Chu PG, Achuthan S, Batra SK, Kulkarni P, Salgia R. Mirzapoiazova T, et al. Among authors: nasser mw. J Clin Med. 2019 Oct 18;8(10):1723. doi: 10.3390/jcm8101723. J Clin Med. 2019. PMID: 31635288 Free PMC article.
A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study.
Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, Tijerina J, Pivovar S, Lakshmanan I, Ketcham M, Rauth S, Mallya K, Nasser MW, Jain M, Kessinger A, Batra SK, Ganti AK. Ernani V, et al. Among authors: nasser mw. Cancer Treat Res Commun. 2020;22:100162. doi: 10.1016/j.ctarc.2019.100162. Epub 2019 Oct 7. Cancer Treat Res Commun. 2020. PMID: 31675535 Free PMC article. Clinical Trial.
MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).
Kanchan RK, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel DL, Donson AM, Perry D, Punsoni M, Talmon GA, Coulter DW, Boue' DR, Snuderl M, Nasser MW, Batra SK, Vibhakar R, Mahapatra S. Kanchan RK, et al. Among authors: nasser mw. Brain Pathol. 2020 Jul;30(4):732-745. doi: 10.1111/bpa.12829. Epub 2020 Mar 30. Brain Pathol. 2020. PMID: 32145124 Free PMC article.
80 results